OrbusNeich unveils device to prevent restenosis in DAPT patients

05/29/2013 | MedGadget.com

OrbusNeich has introduced its COMBO Dual Therapy Stent, designed to prevent the recurrence of stenosis, or narrowed blood vessels, in patients undergoing dual antiplatelet therapy. The sirolimus-eluting stent is covered with Anti-CD34 antibodies that absorb endothelial progenitor cells from passing blood to speed up the healing process.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN